Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,103,589 articles, preprints and more)

Search results

1-25 of 144 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2 3 Next ...

Preliminary efficacy of [⁹⁰Y]DOTA-biotin-avidin radiotherapy against non-muscle invasive bladder cancer.
Alì A, Leibowitz D, Bhatt N, Doubrovin M, Spina CS, Bates-Pappas GE, Taub RN, McKiernan JM, Mintz A, Molotkov A
Eur J Nucl Med Mol Imaging, 50(3):692-700, 09 Nov 2022
Cited by: 1 article | PMID: 36350400
Add to export list
Preliminary efficacy of [90Y] DOTA-biotin-avidin radiotherapy against non-muscle invasive bladder cancer
Alì A, Leibowitz D, Bhatt N, Doubrovin M, Bates-Pappas GE, Taub RN, McKiernan JM, Mintz A, Molotkov A
Research Square, 26 Apr 2022
Cited by: 0 articles | PPR: PPR485889
Add to export list Preprint v1
Two-Stage Cytoreductive Surgery and Intraperitoneal Chemotherapy for Diffuse Malignant Peritoneal Mesothelioma: Predictors of Overall Survival in an Intention-to-Treat Series.
Leinwand JC, Taub RN, Chabot JA, Kluger MD
Ann Surg Oncol, 27(7):2539-2547, 12 Dec 2019
Cited by: 3 articles | PMID: 31832913
Add to export list
50 Patients with Malignant Mesothelioma of Both the Pleura and Peritoneum: A Single-Institution Experience.
Letica-Kriegel AS, Leinwand JC, Sonett JR, Gorenstein LA, Taub RN, Chabot JA, Kluger MD
Ann Surg Oncol, 27(1):205-213, 07 May 2019
Cited by: 2 articles | PMID: 31065962
Add to export list
Recurrence of Optimally Treated Malignant Peritoneal Mesothelioma with Cytoreduction and Heated Intraperitoneal Chemotherapy.
Heller DR, Chiuzan C, Taub RN, Leinwand JC, Greene AM, Bates GE, Chabot JA, Kluger MD
Ann Surg Oncol, 24(13):3818-3824, 12 Oct 2017
Cited by: 3 articles | PMID: 29027138
Add to export list
Intimacy, Body Image, and Cancer.
Bates G, Taub RN, West HJ
JAMA Oncol, 2(12):1667, 01 Dec 2016
Cited by: 2 articles | PMID: 27711916
Add to export list
PICASSO III: A Phase III, Placebo-Controlled Study of Doxorubicin With or Without Palifosfamide in Patients With Metastatic Soft Tissue Sarcoma.
Ryan CW, Merimsky O, Agulnik M, Blay JY, Schuetze SM, Van Tine BA, Jones RL, Elias AD, Choy E, Alcindor T, Keedy VL, Reed DR, Taub RN, Italiano A, Garcia Del Muro X, Judson IR, Buck JY, Lebel F, Lewis JJ, [...] Schöffski P
J Clin Oncol, 34(32):3898-3905, 30 Sep 2016
Cited by: 83 articles | PMID: 27621408
Add to export list
Approach to offering remote support to mesothelioma patients: the mesothelioma survivor project.
Bates GE, Hashmi AK, Bressler T, Zajac J, Hesdorffer M, Taub RN
Transl Lung Cancer Res, 5(3):216-218, 01 Jun 2016
Cited by: 0 articles | PMID: 27413697 | PMCID: PMC4931139
Add to export list Free full text in Europe PMC
Genome-wide analysis of abdominal and pleural malignant mesothelioma with DNA arrays reveals both common and distinct regions of copy number alteration.
Borczuk AC, Pei J, Taub RN, Levy B, Nahum O, Chen J, Chen K, Testa JR
Cancer Biol Ther, 17(3):328-335, 06 Feb 2016
Cited by: 27 articles | PMID: 26853494 | PMCID: PMC4847993
Add to export list Free full text in Europe PMC
Fertility and Cancer Treatment.
Bates GE, Taub RN, West H
JAMA Oncol, 2(2):284, 01 Feb 2016
Cited by: 8 articles | PMID: 26822339
Add to export list
Prognostic significance of morphological growth patterns and mitotic index of epithelioid malignant peritoneal mesothelioma.
Krasinskas AM, Borczuk AC, Hartman DJ, Chabot JA, Taub RN, Mogal A, Pingpank J, Bartlett D, Dacic S
Histopathology, 68(5):729-737, 16 Oct 2015
Cited by: 12 articles | PMID: 26272336
Add to export list
Clinical utility of 18F-FDG positron emission tomography in malignant peritoneal mesothelioma.
Domènech-Vilardell A, Rasiej MJ, Taub RN, Ichise M
Q J Nucl Med Mol Imaging, 60(1):54-61, 14 Apr 2014
Cited by: 11 articles | PMID: 24727854
Add to export list
Quantitative X-ray computed tomography peritoneography in malignant peritoneal mesothelioma patients receiving intraperitoneal chemotherapy.
Leinwand JC, Zhao B, Guo X, Krishnamoorthy S, Qi J, Graziano JH, Slavkovic VN, Bates GE, Lewin SN, Allendorf JD, Chabot JA, Schwartz LH, Taub RN
Ann Surg Oncol, 20 Suppl 3:S553-9, 24 May 2013
Cited by: 5 articles | PMID: 23702640 | PMCID: PMC3853374
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Body surface area predicts plasma oxaliplatin and pharmacokinetic advantage in hyperthermic intraoperative intraperitoneal chemotherapy.
Leinwand JC, Bates GE, Allendorf JD, Chabot JA, Lewin SN, Taub RN
Ann Surg Oncol, 20(4):1101-1104, 02 Mar 2013
Cited by: 8 articles | PMID: 23456384 | PMCID: PMC3599209
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Utility of glucose transporter 1 in the distinction of benign and malignant thoracic and abdominal mesothelial lesions.
Lagana SM, Taub RN, Borczuk AC
Arch Pathol Lab Med, 136(7):804-809, 01 Jul 2012
Cited by: 20 articles | PMID: 22742553
Add to export list
A multicenter phase II study of cisplatin, pemetrexed, and bevacizumab in patients with advanced malignant mesothelioma.
Dowell JE, Dunphy FR, Taub RN, Gerber DE, Ngov L, Yan J, Xie Y, Kindler HL
Lung Cancer, 77(3):567-571, 04 Jul 2012
Cited by: 44 articles | PMID: 22770372
Add to export list
PPARγ agonists enhance ET-743-induced adipogenic differentiation in a transgenic mouse model of myxoid round cell liposarcoma.
Charytonowicz E, Terry M, Coakley K, Telis L, Remotti F, Cordon-Cardo C, Taub RN, Matushansky I
J Clin Invest, 122(3):886-898, 01 Feb 2012
Cited by: 50 articles | PMID: 22293175 | PMCID: PMC3287226
Add to export list Free full text in Europe PMC
Adjuvant chemotherapy in 2011 for patients with soft-tissue sarcoma.
Matushansky I, Taub RN
Nat Rev Clin Oncol, 8(7):434-438, 22 Mar 2011
Cited by: 9 articles | PMID: 21423256
Add to export list Review
Two-stage operative cytoreduction and intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma: Operative morbidity and mortality in phase I and II trials.
Kluger MD, Taub RN, Hesdorffer M, Jin Z, Chabot JA
Eur J Surg Oncol, 36(10):997-1003, 02 Aug 2010
Cited by: 14 articles | PMID: 20674253
Add to export list
Phase II Study of Temozolomide and Thalidomide in Patients with Unresectable or Metastatic Leiomyosarcoma.
Boyar MS, Hesdorffer M, Keohan ML, Jin Z, Taub RN
Sarcoma, 2008:412503, 16 Nov 2008
Cited by: 13 articles | PMID: 19043564 | PMCID: PMC2583339
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Phase II trial of pemetrexed and gemcitabine in chemotherapy-naive malignant pleural mesothelioma.
Jänne PA, Simon GR, Langer CJ, Taub RN, Dowlati A, Fidias P, Monberg M, Obasaju C, Kindler H
J Clin Oncol, 26(9):1465-1471, 01 Mar 2008
Cited by: 25 articles | PMID: 18349397
Add to export list
Combined resection, intraperitoneal chemotherapy, and whole abdominal radiation for the treatment of malignant peritoneal mesothelioma.
Hesdorffer ME, Chabot JA, Keohan ML, Fountain K, Talbot S, Gabay M, Valentin C, Lee SM, Taub RN
Am J Clin Oncol, 31(1):49-54, 01 Feb 2008
Cited by: 28 articles | PMID: 18376228
Add to export list
Gemcitabine and cisplatin in unresectable malignant mesothelioma of the pleura: a phase II study of the Southwest Oncology Group (SWOG 9810).
Kalmadi SR, Rankin C, Kraut MJ, Jacobs AD, Petrylak DP, Adelstein DJ, Keohan ML, Taub RN, Borden EC
Lung Cancer, 60(2):259-263, 19 Nov 2007
Cited by: 37 articles | PMID: 18006112 | PMCID: PMC2702658
Add to export list Free full text in Europe PMC
New strategies for treating GIST when imatinib fails.
Boyar MS, Taub RN
Cancer Invest, 25(5):328-335, 01 Aug 2007
Cited by: 2 articles | PMID: 17661208
Add to export list
Molecular profiling of malignant peritoneal mesothelioma identifies the ubiquitin-proteasome pathway as a therapeutic target in poor prognosis tumors.
Borczuk AC, Cappellini GC, Kim HK, Hesdorffer M, Taub RN, Powell CA
Oncogene, 26(4):610-617, 24 Jul 2006
Cited by: 28 articles | PMID: 16862182
Add to export list

1-25 of 144 results

1 2 3 Next ...

Search life-sciences literature (45,103,589 articles, preprints and more)

Search results

Partnerships & funding